pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·1d ago·1 min read
save

FDA device officials prioritize hiring after layoffs, express optimism for upcoming MDUFA VI agreement

Oct 21, 2026·read at raps ↗RegulatoryPositive

Top officials from the FDA's Center for Devices and Radiological Health spoke at a town‑hall session during The MedTech Conference. They said the agency is concentrating on rebuilding staff after a reduction‑in‑force that took place last year.

The panel highlighted that the primary goal is to recruit new talent to fill the gaps left by the layoffs. Restaffing is being treated as a critical step to maintain the agency's regulatory workload.

Officials also conveyed confidence that the upcoming Medical Device User Fee Amendments (MDUFA VI) negotiations will be productive, suggesting a positive outlook for the next fee cycle.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Tarver: CDRH on a ‘recruiting tear,’ looking ahead to MDUFA VI”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLE
topics
Medical Device Company2

related stories

  • Oct 14J&J’s disappointing Q3, RevMed’s subgroup data, BMS’ ‘mixed’ results, Caribou’s cutbackBioSpace
  • Oct 6GE HealthCare to acquire Sofie Biosciences for $945MBioPharma Dive
  • Oct 5FDA signs off on first heart valve designed to dynamically expand in childrenFierce Biotech
  • Jun 18What’s next for GLP-1 weight loss drugs?STAT
  • Jun 15Lilly scores early positive data for new JAK drugBioPharma Dive